Showing results (981-990 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|April 17, 2013
Interactions between oral antineoplastic agents and concomitant medication: a systematic reviewEsther Carcelero, Helena Anglada, Montse Tuset, et al.Expert Opinion on Drug Safety|March 20, 2013
Application site adverse events associated with the buprenorphine transdermal system: a pooled analysisWarren Wen, Shau Yu Lynch, Catherine Munera, et al.Expert Opinion on Drug Safety|November 21, 2012
Anticoagulants, renal failure and atrial fibrillationSimonetta Genovesi, Antonio SantoroExpert Opinion on Drug Safety|May 9, 2012
Safety and tolerability of antipsychotic polypharmacyJuan A Gallego, Jimmi Nielsen, Marc De Hert, et al.Expert Opinion on Drug Safety|May 15, 2013
Cancer immunotherapies, their safety and toxicityGheath Alatrash, Haroon Jakher, Patricia D Stafford, et al.Expert Opinion on Drug Safety|April 9, 2013
Cardiovascular toxicity of tyrosine kinase inhibitorsElie Mouhayar, Jean-Bernard Durand, Jorge CortesExpert Opinion on Drug Safety|May 8, 2013
Indications and safety of proton pump inhibitor drug use in patients with cancerGeorge Triadafilopoulos, Andrew K Roorda, Junichi AkiyamaExpert Opinion on Drug Safety|May 9, 2013
Cardiovascular safety and hemodynamic considerations in oncology drug development - webinar highlights October 10th 2012Martin Braddock, Jeff Heilbraun, Boaz MendzelevskiExpert Opinion on Drug Safety|March 14, 2013
Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugsVishvas Garg, Dennis W Raisch, June M McKoy, et al.Expert Opinion on Drug Safety|March 16, 2013
The controversy of a wider statin utilization: why?Ishak Mansi, Eric MortensenPageof 282